Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Polí­ticas Farmacêuticas: a Serviçodos Interesses da Saúde?

By José Augusto Cabral Barros


This text stems from a research project aimed at evaluating actual drug
policies particularly those related to the harmonization of regulatory processes
within the European Union and at the international level as well.
Firstly the role of drugs is evaluated in regards to pharmaceutical industry
and economic interests involved in emphasizing the “medicalization” phenomenon
viewed as a consequence of drug manufacturers promotional strategies directed
to consumers and physicians.
The second chapter is dedicated to describing harmonization of regulation
of drugs worldwide.
Moreover, the globalisation and neoliberal economic reforms and
their impact to the access to pharmaceuticals are briefly analysed, as well as
different initiatives to promote rational use and access to essential medicaments.
Finally some conclusions emerge in the light of the pharmaceutical
sector situation; an analysis is put forth, and proposals are presented in order to
improve drug usage in the interest of public health.


Next Section:
INTRODUÇÃO: Papel assumido pelos medicamentos e alguns dos seus determinantes

Previous Section:

Books homepage

Políticas Farmaceuticas homepage



Our members can see and make comments on this page.


  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Click to Register

(read more)

Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts

If there is something you don't like, please tell us. If you like our work, please tell others. The contents of this page are the author's views and do not necessarily reflect the position of Healthy Skepticism or other members of Healthy Skepticism.

Please log in to access sharing tools. influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.